Qube Research & Technologies (QRT)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,164,162	Closed	-$16.9M	–	3545
2025 Q4	$16.9M	Sell	2,164,162 -246,200	-10%	-$1.78M	0.02%	1008
2025 Q3	$18.3M	Buy	2,410,362 +36,873	+2%	+$307K	0.03%	940
2025 Q2	$21.3M	Buy	2,373,489 +1,432,824	+152%	+$13.3M	0.03%	846
2025 Q1	$7.05M	Buy	940,665 +667,821	+245%	+$5.39M	0.01%	1346
2024 Q4	$2.05M	Buy	272,844 +18,943	+7%	+$144K	﹤0.01%	1868
2024 Q3	$1.93M	Buy	+253,901	New	+$1.93M	﹤0.01%	1774
2024 Q2	–	Sell	-667,394	Closed	-$3.39M	–	3822
2024 Q1	$3.39M	Sell	667,394 -361,109	-35%	-$2.03M	0.01%	1449
2023 Q4	$6.16M	Buy	+1,028,503	New	+$5.96M	0.01%	934
2023 Q3	–	Sell	-214,095	Closed	-$1.51M	–	4093
2023 Q2	$1.51M	Buy	+214,095	New	+$1.72M	0.01%	1156
2021 Q3	–	Sell	-40,503	Closed	-$640K	–	2209
2021 Q2	$640K	Sell	40,503 -5,749	-12%	-$78.1K	0.01%	1152
2021 Q1	$470K	Buy	+46,252	New	+$477K	0.01%	1218
2020 Q3	–	Sell	-220,891	Closed	-$1.05M	–	1684
2020 Q2	$1.05M	Buy	+220,891	New	+$882K	0.02%	847
2020 Q1	–	Sell	-14,836	Closed	-$51K	–	1141
2019 Q4	$51K	Buy	+14,836	New	+$37.3K	﹤0.01%	1480